US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
NASDAQ
Keros Therapeutics Inc (KROS)
Keros Therapeutics Inc (KROS) ニュース

Keros Therapeutics Inc (KROS)

11.65

0.62

(5.62%)

終了 7月8日 5:00AM

11.65

0.005

(0.04%)

取引時間後: 7:35AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Keros Therapeutics Appoints Anne Prener to its Board of Directors

LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

TheFinalCD

TheFinalCD 1年前

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events— Bio Stocks™ (@BioStocks) January 15, 2025

$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2
$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2— Bio Stocks™ (@BioStocks) January 15, 2025

retireat40

retireat40 2年前

Wow. What a turd

retireat40

retireat40 2年前

Shocked this is still sub 18

Dennis14

Dennis14 2年前

Bought in at 18.00

Monksdream

Monksdream 2年前

KROS more upside possible

Monksdream

Monksdream 2年前

KROS new 52=week high

Keros Therapeutics

Industrie De Nora

SP Group AS (PK)

Indonesian Rupiah Repo R...

UY Scuti Acquisition

Eternal Hospitality

Gold Basin Resources

Brookfield Asset Managem...

ClearBridge All Cap Grow...

JPMorgan UK Small Cap Gr...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。